NCT00964821 Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplant Status COMPLETED Phase N/A
NCT00963872 Donor Umbilical Cord Blood Transplant After Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT00961064 A Pilot Study of a Thrombopoietin-Receptor Agonist, Eltrombopag, in Patients With Low to Int-2 Risk Myelodysplastic Syndrome (MDS) Status COMPLETED Phase PHASE2
NCT00952185 Influenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy Volunteers Status TERMINATED Phase NA
NCT00949117 Cyproheptadine Hydrochloride and Nutritional Supplementation in Treating Young Patients With Weight Loss With Cancer Status TERMINATED Phase PHASE2
NCT00946647 A Phase Ib/IIb, Open-label, Multi-center, Study of Oral Panobinostat Administered With 5-Azacitidine (in Adult Patients With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML). Status COMPLETED Phase PHASE1/PHASE2
NCT00946283 Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome Status TERMINATED Phase NA
NCT00940602 Myelodysplastic Syndromes (MDS) Event Free Survival With Iron Chelation Therapy Study Status COMPLETED Phase PHASE2
NCT00935090 3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer Status ACTIVE_NOT_RECRUITING Phase N/A
NCT00923234 Combination of 5-azacitidine and Lenalidomide in Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML) Myelodysplastic Syndromes Status TERMINATED Phase PHASE1
NCT00919425 S9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer Status COMPLETED Phase N/A
NCT00916227 A Study of ARRY-614 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndrome Status COMPLETED Phase PHASE1
NCT00915811 Pilot Study of Reduced Intensity Haematopoietic Stem Cell Transplantation in Patients With Poor Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukaemia (AML) Utilising Conditioning With Fludarabine, Busulphan and Thymoglobulin Status TERMINATED Phase PHASE2
NCT00915785 Azacytidine for the Treatment of Myelodysplastic Syndromes/Acute Myeloid Leukemia (MDS/AML) With High Risk (Chromosome 7 and or Complex) Cytogenetic Abnormalities Status COMPLETED Phase PHASE2
NCT00914940 Selective Depletion of CD45RA+T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD Status TERMINATED Phase PHASE2
NCT00909467 Early Recognition of Pulmonary Arterial Hypertension in Myelodysplastic and Myeloproliferative Diseases Status COMPLETED Phase N/A
NCT00900406 Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant Status COMPLETED Phase N/A